Merz Aesthetics
Bonnie Safyurtlu RAC is an accomplished regulatory affairs professional with extensive experience in the biotechnology and aesthetics industries. Currently serving as Vice President of Global Regulatory Affairs at Merz Aesthetics since February 2021, Bonnie is a key member of the Aesthetics Global R&D Leadership Team and leads the Global Regulatory Affairs Leadership Team. Previously, Bonnie held the position of Director of Regulatory Affairs at Allergan Inc from January 2006 to October 2020, acting as the primary contact with the FDA and leading global regulatory project teams. Earlier roles include Manager of Regulatory Affairs at Amgen Inc, where Bonnie oversaw regulatory strategy for oncology products, and Regulatory Affairs Specialist at Xoma. Bonnie holds a Bachelor of Science in Biology from the Rochester Institute of Technology and a Master of Science in Regulatory Science from the University of Southern California.
This person is not in any teams
This person is not in any offices
Merz Aesthetics
6 followers
Merz Aesthetics is a medical aesthetics business with a long history of empowering health care professionals, patients and employees to live every day with confidence. We aim to help people around the world look, feel and live like the best versions of themselves — however they define it. Clinically proven, its product portfolio includes injectables, devices and skin care treatments designed to meet each patient’s needs with high standards of safety and efficacy. Being family owned for more than 115 years, Merz Aesthetics is known for building unique connections with customers who feel like family. Merz Aesthetics’ global headquarters is in Raleigh, N.C., USA, with a commercial presence in 90 countries worldwide. It is also a part of Merz Group, which was founded in 1908 and is based in Frankfurt, Germany. Learn more at merzaesthetics.com.